Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Franchini M, Mengoli C, Caruso B, Petilino R, Ballotari A, Glingani C. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma. Clin Chem Lab Med 2022;60:e4-e6. [PMID: 34472761 DOI: 10.1515/cclm-2021-0810] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2021] [Accepted: 08/17/2021] [Indexed: 11/15/2022]

For:	Franchini M, Mengoli C, Caruso B, Petilino R, Ballotari A, Glingani C. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma. Clin Chem Lab Med 2022;60:e4-e6. [PMID: 34472761 DOI: 10.1515/cclm-2021-0810] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2021] [Accepted: 08/17/2021] [Indexed: 11/15/2022]

Number

Cited by Other Article(s)

Favresse J, Douxfils J, Henry B, Lippi G, Plebani M. Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2. Clin Chem Lab Med 2022;61:811-821. [PMID: 36420539 DOI: 10.1515/cclm-2022-1166] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2022] [Accepted: 11/16/2022] [Indexed: 11/25/2022]

Grubovic Rastvorceva RM, Useini S, Stevanovic M, Demiri I, Petkovic E, Franchini M, Focosi D. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial. Life (Basel) 2022;12:1565. [PMID: 36295001 PMCID: PMC9605182 DOI: 10.3390/life12101565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Revised: 09/14/2022] [Accepted: 09/27/2022] [Indexed: 01/24/2023] Open

Abstract

Background: COVID-19 convalescent plasma (CCP) is an important antiviral option for selected patients with COVID-19. Materials and Methods: In this open-label, phase 2, clinical trial conducted from 30 April 2020 till 10 May 2021 in the Republic of North Macedonia, we evaluated the efficacy and safety of CCP in hospitalized patients. Treatment was with a single unit of CCP having an anti-RBD IgG concentration higher than 5 AU/mL. Results: There were 189 patients that completed the study, of which 65 (34.4%) had WHO 8-point clinical progression scale score of 3 (requiring hospital care but not oxygen support), 65 (34.4%) had a score of 4 (hospitalized and requiring supplemental oxygen by mask or nasal prongs), and 59 (31.2%) had a score of 5 (hospitalized and requiring supplemental oxygen by non-invasive ventilation or high-flow oxygen). Mean age was 57 years (range 22−94), 78.5% were males, 80.4% had elevated body mass index, and 70.9% had comorbidity. Following CCP transfusion, we observed clinical improvement with increase rates in oxygenation-free days of 32.3% and 58.5% at 24 h and seven days after CCP transfusion, a decline in WHO scores, and reduced progression to severe disease (only one patient was admitted to ICU after CCP transfusion). Mortality in the entire cohort was 11.6% (22/189). We recorded 0% mortality in WHO score 3 (0/65) and in patients that received CCP transfusion in the first seven days of disease, 4.6% mortality in WHO score 4 (3/65), and 30.5% mortality in WHO score 5 (18/59). Mortality correlated with WHO score (Chi-square 19.3, p < 0.001) and with stay in the ICU (Chi-square 55.526, p ≤ 0.001). No severe adverse events were reported. Conclusions: This study showed that early administration of CCP to patients with moderate disease was a safe and potentially effective treatment for hospitalized COVID-19 patients. The trial was registered at clinicaltrials.gov (NCT04397523).

Collapse

Franchini M, Glingani C, Donno GD, Lucchini G, Beccaria M, Amato M, Castelli GP, Bianciardi L, Pagani M, Ghirardini M, Puma G, Presciuttini B, Costantino MT, Frigato M, Crosato V, Tiecco G, Mulè A, Papalia DA, Inglese F, Spreafico F, Garuti M, Pecoriello A, Cervi G, Greco G, Galavotti V, Santini T, Berselli A, Montalto C, Bertoletti R, Bellometti SA, Capuzzo E, Benazzi D, Grisolia G, Pajola F, Stradoni R, Zani M, Verzola A, Codeluppi V, Vesentini S, Bellocchio E, Candini M, Ambrosi G, Carandina F, Scarduelli C, Reggiani A, Casari S. Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience. Life (Basel) 2022;12:life12030420. [PMID: 35330170 PMCID: PMC8950373 DOI: 10.3390/life12030420] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2022] [Revised: 03/07/2022] [Accepted: 03/11/2022] [Indexed: 12/20/2022] Open

Affiliation(s)

Massimo Franchini Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (C.G.); (E.C.); (M.Z.) Correspondence: ; Tel.: +39-0376-201234; Fax: +39-0376-220144
Claudia Glingani Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (C.G.); (E.C.); (M.Z.)
Giuseppe De Donno Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Giuseppe Lucchini Biostatistic Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy;
Massimiliano Beccaria Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Massimo Amato Emergency Department, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.A.); (D.B.)
Gian Paolo Castelli Department of Anesthesiology and Intensive Care, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.P.C.); (A.B.); (C.M.)
Leonardo Bianciardi Anesthesiology and Intensive Care Unit, SS Trinità and San Marcellino Muravera (Cagliari) Hospital, ASL 8 Cagliari, 09043 Cagliari, Italy;
Mauro Pagani Internal Medicine Unit, Department of Medicine, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.P.); (B.P.)
Marco Ghirardini Department of Medicine, Hospital of Asola, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.G.); (T.S.)
Giuseppe Puma Unit of Infectious Diseases, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.P.); (S.C.)
Barbara Presciuttini Internal Medicine Unit, Department of Medicine, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.P.); (B.P.)
Maria Teresa Costantino Allergology and Clinical Immunology Unit, Department of Medicine, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.T.C.); (M.F.)
Marilena Frigato Allergology and Clinical Immunology Unit, Department of Medicine, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.T.C.); (M.F.)
Verena Crosato Infectious and Tropical Diseases Clinic, University of Brescia and Azienda Socio Sanitaria Territoriale Spedali Civili, 25123 Brescia, Italy; (V.C.); (G.T.); (A.M.); (D.A.P.)
Giorgio Tiecco Infectious and Tropical Diseases Clinic, University of Brescia and Azienda Socio Sanitaria Territoriale Spedali Civili, 25123 Brescia, Italy; (V.C.); (G.T.); (A.M.); (D.A.P.)
Alice Mulè Infectious and Tropical Diseases Clinic, University of Brescia and Azienda Socio Sanitaria Territoriale Spedali Civili, 25123 Brescia, Italy; (V.C.); (G.T.); (A.M.); (D.A.P.)
Dorothea Angela Papalia Infectious and Tropical Diseases Clinic, University of Brescia and Azienda Socio Sanitaria Territoriale Spedali Civili, 25123 Brescia, Italy; (V.C.); (G.T.); (A.M.); (D.A.P.)
Francesco Inglese Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Fabio Spreafico Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Martina Garuti Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Antonietta Pecoriello Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Giulia Cervi Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Graziana Greco Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Vanni Galavotti Intensive Care Respiratory Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.D.D.); (M.B.); (F.I.); (F.S.); (M.G.); (A.P.); (G.C.); (G.G.); (V.G.)
Tiziana Santini Department of Medicine, Hospital of Asola, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.G.); (T.S.)
Angela Berselli Department of Anesthesiology and Intensive Care, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.P.C.); (A.B.); (C.M.)
Carlo Montalto Department of Anesthesiology and Intensive Care, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.P.C.); (A.B.); (C.M.)
Riccardo Bertoletti Medical Direction, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (R.B.); (S.A.B.); (F.P.)
Simona Aurelia Bellometti Medical Direction, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (R.B.); (S.A.B.); (F.P.)
Enrico Capuzzo Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (C.G.); (E.C.); (M.Z.)
Dario Benazzi Emergency Department, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (M.A.); (D.B.)
Gianpaolo Grisolia Department of Obstetrics and Gynecology, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy;
Fabio Pajola Medical Direction, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (R.B.); (S.A.B.); (F.P.)
Raffaello Stradoni General Direction, Azienda Socio Sanitaria Territoriale of Valcamonica, 25043 Breno, Italy;
Matteo Zani Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (C.G.); (E.C.); (M.Z.)
Adriano Verzola Management Planning and Control Service, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy;
Vito Codeluppi Department of Anesthesiology and Intensive Care, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (V.C.); (S.V.); (E.B.); (M.C.); (G.A.); (F.C.)
Silvia Vesentini Department of Anesthesiology and Intensive Care, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (V.C.); (S.V.); (E.B.); (M.C.); (G.A.); (F.C.)
Elisa Bellocchio Department of Anesthesiology and Intensive Care, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (V.C.); (S.V.); (E.B.); (M.C.); (G.A.); (F.C.)
Marco Candini Department of Anesthesiology and Intensive Care, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (V.C.); (S.V.); (E.B.); (M.C.); (G.A.); (F.C.)
Giorgina Ambrosi Department of Anesthesiology and Intensive Care, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (V.C.); (S.V.); (E.B.); (M.C.); (G.A.); (F.C.)
Francesca Carandina Department of Anesthesiology and Intensive Care, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (V.C.); (S.V.); (E.B.); (M.C.); (G.A.); (F.C.)
Cleante Scarduelli Intensive Cardiopulmonary Rehabilitation Unit, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy;
Albino Reggiani Cardiology Unit, Destra Secchia Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy;
Salvatore Casari Unit of Infectious Diseases, Carlo Poma Hospital, Azienda Socio Sanitaria Territoriale of Mantova, 46100 Mantova, Italy; (G.P.); (S.C.)
on behalf of Convalescent Plasma Study Group

Collapse